Edition:
India

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

689.55INR
12:09pm IST
Change (% chg)

Rs-13.95 (-1.98%)
Prev Close
Rs703.50
Open
Rs703.00
Day's High
Rs704.70
Day's Low
Rs687.60
Volume
764,246
Avg. Vol
3,253,317
52-wk High
Rs895.00
52-wk Low
Rs503.05

ARBN.NS

Chart for ARBN.NS

About

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system,... (more)

Overall

Beta: 0.94
Market Cap(Mil.): Rs418,261.41
Shares Outstanding(Mil.): 585.88
Dividend: 1.25
Yield (%): 0.55

Financials

  ARBN.NS Industry Sector
P/E (TTM): 18.67 30.82 32.14
EPS (TTM): 38.23 -- --
ROI: -- 14.45 13.99
ROE: -- 15.54 15.33

MEDIA-Aurobindo Pharma, Intas in race for Teva’s European assets; bids expected to be above $1 bln - Mint

- Note: Reuters has not verified this story and does not vouch for its accuracy

16 Aug 2017

MEDIA-Aurobindo Pharma, Intas vying for Teva Pharma's European assets- Mint

-- Note: Reuters has not verified this story and does not vouch for its accuracy

16 Aug 2017

BUZZ-India's Aurobindo Pharma rises after Q1 results

** Shares of Aurobindo Pharma Ltd rise as much as 5.6 pct to 722.00 rupees, their biggest intraday pct gain since July 19 ** Shares of India's third largest drugmaker by sales top pct gainer on the NSE index ** Company reported a 11 pct fall in quarterly profit on Wednesday, hurt by lower sales from formulations business in the U.S. and disruptions related to the launch of Goods and Services Tax in India

10 Aug 2017

Aurobindo Pharma first-quarter profit drops 11 percent, misses estimates

Drugmaker Aurobindo Pharma Ltd reported a 11 percent fall in quarterly profit, hurt by lower sales from its formulations business in the U.S. and pre-launch disruptions of a pan-India tax reform.

09 Aug 2017

UPDATE 1-Aurobindo Pharma Q1 profit drops 11 pct, misses estimates

Aug 9 Indian drugmaker Aurobindo Pharma Ltd reported a 11 percent fall in quarterly profit, hurt by lower sales from its formulations business in the U.S. and pre-launch disruptions of a pan-India tax reform.

09 Aug 2017

BRIEF-India's Aurobindo Pharma June-qtr consol profit down about 11 pct

* June quarter consol net profit 5.19 billion rupees versus 5.85 billion rupees last year

09 Aug 2017

Sensex closes higher; Aurobindo Pharma leads

Indian shares recovered on Wednesday as cigarette maker ITC rebounded and drugmakers gained on hopes of U.S. regulatory approvals and the launches of new drugs.

19 Jul 2017

Indian shares close higher; Aurobindo Pharma leads

July 19 Indian shares recovered on Wednesday as cigarette maker ITC rebounded and drugmakers gained on hopes of U.S. regulatory approvals and the launches of new drugs.

19 Jul 2017

Indian shares rise as drugmakers, consumer stocks gain

July 19 Indian shares rose on Wednesday, with drugmaker Aurobindo Pharma Ltd up on hopes of higher U.S. sales and consumer staple Hindustan Unilever hitting a record high after its June-quarter profit beat expectations.

19 Jul 2017

BUZZ-Indian drug maker shares rise; Aurobindo Pharma hits 8-mth high

** Nifty Pharma index rises as much as 1.8 pct to its highest since May 19; index on track to post sixth straight session of gains

19 Jul 2017

Earnings vs. Estimates